Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) YoY EBITDA Growth : -73.68% (As of Dec. 2014)

View and export this data going back to 2007. Start your Free Trial

What is Omni Bio Pharmaceutical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Omni Bio Pharmaceutical's YoY EBITDA Growth for the quarter that ended in Dec. 2014 was -73.68%.

Omni Bio Pharmaceutical's EBITDA per Share for the three months ended in Dec. 2014 was $-0.03.

Omni Bio Pharmaceutical YoY EBITDA Growth Historical Data

The historical data trend for Omni Bio Pharmaceutical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omni Bio Pharmaceutical YoY EBITDA Growth Chart

Omni Bio Pharmaceutical Annual Data

Trend

Dec06

Dec07

Dec08

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

YoY EBITDA Growth

Get a 7-Day Free Trial

-601.45

40.08

41.03

-32.16

72.12

Omni Bio Pharmaceutical Quarterly Data
	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14
YoY EBITDA Growth	Get a 7-Day Free Trial															71.64	87.95	-5.26	-50.00	-73.68

Omni Bio Pharmaceutical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Omni Bio Pharmaceutical's YoY EBITDA Growth for the fiscal year that ended in Mar. 2014 is calculated as:

	YoY EBITDA Growth (A: Mar. 2014 )
=	(EBITDA per Share (A: Mar. 2014 )	-	EBITDA per Share (A: Mar. 2013 ))	/	\| EBITDA per Share (A: Mar. 2013 ) \|
=	(-0.063	-	-0.226)	/	\| -0.226 \|
=	72.12 %

Omni Bio Pharmaceutical's YoY EBITDA Growth for the quarter that ended in Dec. 2014 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2014 )
=	(EBITDA per Share (Q: Dec. 2014 )	-	EBITDA per Share (Q: Dec. 2013 ))	/	\| EBITDA per Share (Q: Dec. 2013 )) \|
=	(-0.033	-	-0.019)	/	\| -0.019 \|
=	-73.68 %

Omni Bio Pharmaceutical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Omni Bio Pharmaceutical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omni Bio Pharmaceutical Inc (GREY:OMBP) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

5350 South Roslyn, Suite 430, Greenwood Village, CO, USA, 80111

Website

http://www.omnibiopharma.com

Omni Bio Pharmaceutical Inc is a US-based biopharmaceutical company, which is engaged in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naturally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. Further, it focuses on the research and development efforts of advancing its first recombinant molecule, AAT and an Fc component of immunoglobulin (AAT-Fc 2) into clinical trials. Geographically these activities are functioned through the region of US.

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Headlines

No Headlines